STEMCELL Technologies is pleased to announce the acquisition of substantially all assets of SQZ Biotechnologies Company (SQZ)—a Massachusetts-based biotech known for its game-changing method of introducing a variety of therapeutic cargo into cells by squeezing them (mechanoporation) rather than using electricity (electroporation). This is STEMCELL’s second acquisition in the biotechnology sector this year. In January 2024, STEMCELL purchased Propagenix Inc.,
Read the full article: STEMCELL Technologies Announces Successful Asset Purchase Agreement with SQZ Biotechnologies Company //
Source: https://www.businesswire.com/news/home/20240229339343/en/STEMCELL-Technologies-Announces-Successful-Asset-Purchase-Agreement-with-SQZ-Biotechnologies-Company